thymus extract is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-04. Numbers and descriptions here follow the published literature rather than marketing material.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
A computer expert was ultimately able to retrieve much of the data that Kidder had lost on her laptop. In a 2000 interview, Kidder stated that, in addition to causing emotional distress, her manic episodes had led her to experiencing significant financial woes: "I went through millions of dollars—I have no idea how much. I'd buy things for friends, take people to Paris. Once I stayed up for three weeks in a row because I felt like I was called upon to write a new religion for women. I was reading all these books, including the Bible—and I'm an atheist."
Hezbollah's senior leadership faced the heaviest casualties in its entire history during the conflict. According to the IDF, 13 members of Hezbollah's senior command were killed. Its political council lost figures such as Secretary-General Hassan Nasrallah, who ruled the group for over three decades, and his deputy, Hashem Safieddine. Its armed wing lost key leaders such as Fuad Shukr, Hezbollah's military commander; Ibrahim Aqil, Shukr's deputy; and Ali Karaki, the commander of Hezbollah's Southern Front. Hezbollah also saw heavy damage inflicted upon its equipment, missile arsenal and infrastructure in southern Lebanon, weakening its operational capacity. Heavy damage was inflicted upon military infrastructure such as bases, tunnels, weapon depots, and fortifications, and its arms supply has been disrupted by Israeli strikes on Syrian border crossings. According to IDF, they confiscated over 155,000 weapons and pieces of military equipment belonging to Hezbollah, including around 12,000 explosive devices, drones, and other explosive weapons, more than 13,000 anti-tank missile launchers and rockets, and anti-aircraft missiles. In addition, over 121,000 communication devices, computers, electronic equipment and documents were also captured. In April 2025, in response to increasing calls for its disarmament, Hezbollah expressed willingness to engage in discussions about its weapons with Lebanese President Joseph Aoun. These discussions would be contingent upon Israel's withdrawal from five hilltop positions in southern Lebanon and the cessation of its military strikes.
creating non-viral transfection agents, developing preparations for biotechnological production and gene therapy; creating new programmable materials based on hybrid nanoparticles for medicine and biochemistry; developing direct synthesis methods, studying structure and properties of new sulphur derivatives of five-membered oxygen- and nitrogen-containing heterocycles; searching for chemo-, region- and stereo-selective thiating and aminating reactions with the view to create new antimicrobial agents based on studied heterocycles; developing new principles of pathogenic microflora control in collaboration with biologists. New organic synthesis methods are developed here, as well.
Sources: en.wikipedia.org
== Storage == A backup strategy requires an information repository, "a secondary storage space for data" that aggregates backups of data "sources". The repository could be as simple as a list of all backup media (DVDs, etc.) and the dates produced, or could include a computerized index, catalog, or relational database.
They can be fabricated without extreme temperatures or expensive "dry rooms". Their capacity is six times that of commercially available supercapacitors. The device reached volumetric capacitance of over 1,100 F/cm3. This corresponds to a specific capacitance of the constituent MnO2 of 1,145 F/g, close to the theoretical maximum of 1,380 F/g. Energy density varies between 22 and 42 Wh/L depending on device configuration. In May 2015 a boric acid-infused, laser-induced graphene supercapacitor tripled its areal energy density and increased its volumetric energy density 5-10 fold. The new devices proved stable over 12,000 charge-discharge cycles, retaining 90 percent of their capacitance. In stress tests, they survived 8,000 bending cycles.
"The social and psychological functions of popular music [are that it] acts like a social cement" "to keep people obedient and subservient to the status quo of existing power structures." Serious music, according to Adorno, achieves excellence when its whole is greater than the sum of its parts. The example he gives is that of Beethoven's symphonies: "[his] greatness shows itself in the complete subordination of the accidentally private melodic elements to the form as a whole." Standardization not only refers to the products of the culture industry but also to the consumers as well. Many times every day consumers are bombarded by media advertising. Consumers are pushed and shoved into consuming products and services presented to them by a media system that takes advantage of musical hooks mass-produced via electronic media. The masses have become conditioned by the culture industry, which makes the impact of standardization far more widespread. Not recognizing the impact of social media and commercial advertising, the individual is caught in a situation where conformity is the norm: "During consumption, the masses become characterized by the commodities which they use and exchange among themselves." Tony Waters and David Philhour have tested Adorno's ideas and used musical intros from pop songs and asked students in the United States, Germany, and Thailand what they recognize. They found that indeed, as Adorno hypothesized, song intro recognition has spread around the world for some specific commercial pop songs.
Sources: en.wikipedia.org
Trading Corporation of Pakistan (TCP) is the principal trading arm of the Government of Pakistan. Established as an international trading house in 1967, the corporation has gradually moved from barter, through commodity exchange to cash trade. TCP undertakes import of essential commodities to help ensure their availability to the common man at affordable prices.
He believed that some of the effects of increased CO2 levels are favourable and not taken into account by climate scientists, such as increased agricultural yield, and further that the positive benefits of CO2 likely outweigh the negative effects. He was skeptical about the simulation models used to predict climate change, arguing that political efforts to reduce causes of climate change distract from other global problems that should take priority. He was awarded the 1996 Lewis Thomas Prize and the 2000 Templeton Prize. He said that "As we look out into the Universe and identify the many accidents of physics and astronomy that have worked together to our benefit, it almost seems as if the Universe must in some sense have known that we were coming."
The so-called carbamate insecticides feature the carbamate ester functional group (ROC(O)NHR'). Included in this group are aldicarb (Temik), carbofuran (Furadan), carbaryl (Sevin), ethienocarb, fenobucarb, oxamyl, and methomyl. They are synthetic analogues of the toxic alkaloid physostigmine, the study of which led to this class of insecticides. An estimated 25M kg of carbaryl were produced in 1971. These insecticides kill insects by reversibly inactivating the enzyme acetylcholinesterase (AChE inhibition) (IRAC mode of action 1a). Fenoxycarb has a carbamate group but acts as a juvenile hormone mimic, rather than inactivating acetylcholinesterase. The insect repellent icaridin is a substituted carbamate. Besides their common use as arthropodocides/insecticides, they are also nematicidal. One such is Oxamyl. Sales have declined dramatically over recent decades.
== External links == Somatotropin+receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Illustration at nih.gov Overview Growth Hormone Receptor Archived 2015-10-16 at the Wayback Machine: Molecule of the Month by Shuchismita Dutta and David Goodsell (April 2004) PDBe-KB provides an overview of all the structure information available in the PDB for Human Growth hormone receptor
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.